Our study shows a significantly higher p-STAT3/p-STAT1 ratio in the liver fibrosis group, which further increases with anti-IFNAR blockade, suggesting STAT3’s role in mitigating fibrosis. Here, STAT3 is linked to Hepatic fibrosis.